摘要
目的观察酚妥拉明联合多巴胺在婴幼儿肺炎心衰前期的治疗效果。方法肺炎心衰前期患儿118例随机分为2组,对照组58例应用抗感染等常规治疗;治疗组60例在常规治疗同时给予酚妥拉明联合多巴胺微量泵维持。比较心衰发生率及不良反应。结果治疗组心衰发生率15.0%,对照组43.1%,差异明显(χ2=11.36,P<0.01),无不良反应。结论在肺炎心衰前期应用酚妥拉明联合多巴胺,可有效地降低心衰的发生率。
Objective To observe the efficacy of phentolamine anddopamine oninfantile bronchopneumonia. with early heart failure. Methods 118 cases of infantile bronchopneumonia with early heart failure were randomly divided into two groups,60 cases in the treatment group and 58 cases in the control group. The control group were given conventional theraphy such as anti-infection measures. Together with conventional theraphy the treatment group were given phentolamine and dopamine injected continuously by microinfusion pump. To compare the incidence of heart failure and adverse reactions of the two groups. Results Compaired with the control group ,the incidence of heart failure was 15. 0% from the treatment group ,but 43. 1% from the control group. The significant difference was remarkable （ χ^2 = 11. 36,P〈0. 01） and there was no adverse reaction. Conclusion The therapy of phentolamine and dopamine on infantile bronchopneumonia. with early heart failure can reduce the incidence of heart failure,and there was no adverse reaction.
出处
《中国实用医药》
2010年第26期30-32,共3页
China Practical Medicine
关键词
酚妥拉明
多巴胺
肺炎心衰前期
应用
Phentolamine
Dopamine
Infantile Bronchopneumonia with early Heart Failure
Application
